Compare OGN & NEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGN | NEXT |
|---|---|---|
| Founded | 1923 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2020 | 2014 |
| Metric | OGN | NEXT |
|---|---|---|
| Price | $9.69 | $6.80 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $11.75 | $7.50 |
| AVG Volume (30 Days) | 6.4M | ★ 6.5M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.45 | N/A |
| Revenue Next Year | $1.67 | N/A |
| P/E Ratio | $12.94 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $4.75 |
| 52 Week High | $13.25 | $12.12 |
| Indicator | OGN | NEXT |
|---|---|---|
| Relative Strength Index (RSI) | 76.35 | 44.83 |
| Support Level | $8.63 | $6.18 |
| Resistance Level | $10.10 | $7.42 |
| Average True Range (ATR) | 0.58 | 0.60 |
| MACD | 0.42 | -0.18 |
| Stochastic Oscillator | 96.66 | 1.09 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.